June 22, 2018

Texas Medicaid will publish the semi-annual update of the Medicaid preferred drug list on July 26. The update is based on changes presented and recommended at the January and April 2018 Texas Drug Utilization Review Board meetings. Drug list decisions from both the January and April meetings are available. The tables below summarizes noteworthy changes for the July update.

  • New preferred drug class:
    • Movement Disorder

Drugs on the Texas Medicaid formulary are designated as preferred, non-preferred, or have neither designation. The preferred drug list includes only drugs identified as either preferred or non-preferred:

  • Drugs not on the preferred list, or drugs identified on the list as "preferred", are available to people without prior authorization.
  • Drugs on the preferred list that are identified as "non-preferred" will require prior authorization.
  • Some preferred and non-preferred drugs may require clinical prior authorization.
  • The Preferred Drug List Criteria Guide (PDF) outlines the criteria used to evaluate the non-preferred prior authorization requests. It will be updated by July 20 to reflect the recent changes.
Decisions from January DUR meeting
Drug Name Current Status Status as of July 26
Benzaclin with pump ( topical) Preferred Non-preferred
Hysingla ER (oral) Preferred Non-Preferred
Tramadol ER (Ryzolt) (oral) Preferred Non-Preferred
Amlodipine/Valsartan/HCTZ (oral) Preferred Non-Preferred
Tarka (oral) Preferred Non-Preferred
Relpax (Oral) Preferred Non-Preferred
Azelastine (Astelin) (nasal) Non-Preferred Preferred
Flonaze (Furoate) OTC (nasal) Not previously reviewed Non-Preferred
Patanase (nasal) Preferred Non-Preferred
Austedo (Oral) Not previously reviewed Non-Preferred
Ingrezza (oral) Not previously reviewed Non-Preferred
Tetrabenazine (oral) Not previously reviewed Non-Preferred
Xenazine (oral) Not previously reviewed Preferred
Effient (oral) Preferred Non-Preferred
Prasugrel (oral) Non-Preferred Preferred
Nicotine Lozenge OTC (Buccal) Non-Preferred Preferred
Decisions from April DUR meeting
Drug Name Current Status Status as of July 26
Proventil HFA Preferred Non-Preferred
Benzonatate capsule (oral) Preferred Non-Preferred
Pulmicort 0.25, 0.5, 1 mg respules (inhalation) Non-Preferred Preferred
QVAR and QVAR Redihaler Preferred Non-Preferred
Flovent Diskus Preferred Non-Preferred
Eucrisa Non-Preferred Preferred